上海凯赛生物技术股份有限公司2025年第三次临时股东会决议公告

Group 1 - The company held its third extraordinary general meeting of shareholders in 2025, with no resolutions being rejected [2] - The meeting was chaired by Dr. Xiucai Liu, and the procedures complied with the Company Law and the company's articles of association [2][3] - All nine current directors attended the meeting, along with the board secretary and other senior management [3] Group 2 - Three non-cumulative voting proposals were approved: the 2025 Employee Stock Ownership Plan (draft), its management measures, and the authorization for the board to handle related matters [3][4] - The meeting took place on October 15, 2025, at a specified location in Shanghai [3] - The voting results for the proposals were legally valid, and separate counting was conducted for minority investors [4][5]